Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic changes with mepivacaine versus prilocaine + felypressin in controlled hypertensive dental patients
IRCT20200707048045N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in hypertension (HTN) comparing Mepivacaine arm with Prilocaine + felypressin arm (2 arms). Primary endpoints: Change in pulse, Change in blood pressure and 1 more. Started Jun 2020; status: completed.
02
Drugs
mepivacaineprilocainefelypressin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20200707048045N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200707048045N1.